AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist
  • 4.980
  • -0.220-4.23%
20min DelayMarket Closed Jul 5 16:00 AET
1.55BMarket Cap-52421P/E (Static)

Clarity Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities
106.17%6.73M
3.26M
Other cash income from operating activities
106.17%6.73M
--3.26M
Cash paid
-114.63%-35.7M
-16.63M
Payments to suppliers for goods and services
-114.63%-35.7M
---16.63M
Direct interest received
1,989.39%1.58M
--75.62K
Direct tax refund paid
-485.30%-103.2K
---17.63K
Operating cash flow
-106.55%-27.5M
---13.31M
Investing cash flow
Cash flow from continuing investing activities
111.80%3.15M
-26.71M
Net PPE purchase and sale
78.16%-46.56K
---213.15K
Net investment purchase and sale
112.07%3.2M
---26.5M
Cash from discontinued investing activities
Investing cash flow
111.80%3.15M
---26.71M
Financing cash flow
Cash flow from continuing financing activities
-99.73%231.58K
86.93M
Net common stock issuance
-99.80%170.59K
--86.8M
Net other financing activities
-53.79%61K
--132K
Cash from discontinued financing activities
Financing cash flow
-99.73%231.58K
--86.93M
Net cash flow
Beginning cash position
555.72%55.34M
--8.44M
Current changes in cash
-151.42%-24.12M
--46.9M
Effect of exchange rate changes
-85.92%-5.88K
---3.16K
End cash Position
-43.59%31.21M
--55.34M
Free cash from
-103.64%-27.55M
---13.53M
Accounting Standards
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities 106.17%6.73M3.26M
Other cash income from operating activities 106.17%6.73M--3.26M
Cash paid -114.63%-35.7M-16.63M
Payments to suppliers for goods and services -114.63%-35.7M---16.63M
Direct interest received 1,989.39%1.58M--75.62K
Direct tax refund paid -485.30%-103.2K---17.63K
Operating cash flow -106.55%-27.5M---13.31M
Investing cash flow
Cash flow from continuing investing activities 111.80%3.15M-26.71M
Net PPE purchase and sale 78.16%-46.56K---213.15K
Net investment purchase and sale 112.07%3.2M---26.5M
Cash from discontinued investing activities
Investing cash flow 111.80%3.15M---26.71M
Financing cash flow
Cash flow from continuing financing activities -99.73%231.58K86.93M
Net common stock issuance -99.80%170.59K--86.8M
Net other financing activities -53.79%61K--132K
Cash from discontinued financing activities
Financing cash flow -99.73%231.58K--86.93M
Net cash flow
Beginning cash position 555.72%55.34M--8.44M
Current changes in cash -151.42%-24.12M--46.9M
Effect of exchange rate changes -85.92%-5.88K---3.16K
End cash Position -43.59%31.21M--55.34M
Free cash from -103.64%-27.55M---13.53M
Accounting Standards US-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg